Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks under $1 Report

US and Canadian markets settled this week on a mixed note, Two stocks to consider – FLCN, INTS

Oct 09, 2025

  • FLCN:TSX-V
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (CA$)
  • INTS:NASDAQ
  • Investment Type
    Small-Cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Company Overview: Falcon Energy Materials PLC (TSXV: FLCN) is a United Arab Emirates–based integrated supplier of battery anode materials. The company operates through a single business segment focused on the exploration and evaluation of mineral properties. Intensity Therapeutics, Inc. (NASDAQ: INTS) is a late-stage clinical biotechnology company focused on developing therapies that address both the regional and systemic aspects of cancer. The company’s proprietary platform enables the creation of patented anti-cancer product candidates that combine active anti-cancer agents with amphiphilic molecules, designed to enhance therapeutic delivery and efficacy. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.

Global Markets Wrap-Up

U.S. equity markets ended the week on a softer note amid broad-based sector weakness. The S&P 500 slipped 0.08% to close at 6,735.11, while the NASDAQ Composite gained 1.07% to 23,024.63, supported by renewed strength in technology stocks. In contrast, the Russell 2000 declined 0.30%, finishing at 2,468.85.

In Canada, the S&P/TSX Venture Composite Index advanced 3.14% week-to-date (WTD) to close at 994.27, extending its broader uptrend and reinforcing underlying bullish momentum. On Thursday, gains in the technology and consumer non-cyclical sectors provided near-term support, highlighting selective sector strength. However, persistent weakness in real estate, healthcare, financials, basic materials, industrials, and energy partially offset these gains, limiting the index’s overall upside traction.

Considering the US and Canadian markets’ performance over the week, following the significant global macros and data front, two stocks that fit the criteria on the technical framework: Falcon Energy Materials PLC (TSXV: FLCN) and Intensity Therapeutics, Inc. (NASDAQ: INTS). The recommendations on these stocks are based on the generic insights, entry price, target prices, and stop-loss for the next 2-6 weeks:

Falcon Energy Materials PLC (TSXV: FLCN)

Noted below are the key price indicators for the stock:

Price Action Analysis (On the Daily Chart)

On the daily chart, FLCN continues to trade above a falling trendline support, indicating sustained price strength and reinforcing the near-term bullish bias. The stock has shown steady progress and is now approaching a key resistance zone near CAD 0.762, which could be tested over the next 2–6 weeks if current momentum persists. A decisive breakout above CAD 0.840 would serve as a strong bullish catalyst, likely attracting renewed buying interest and potentially paving the way for an extended rally.

Technical Analysis (On the Daily Chart)

The 14-period RSI has rebounded to 76.14, indicating strengthening bullish momentum. This is further supported by robust weekly trading volumes, highlighting sustained buying interest and rising investor confidence. Additionally, price action remains firmly above the 21-period Simple Moving Average (SMA), a key short-term trend indicator expected to act as near-term support and reinforce the positive technical outlook.

General Recommendation:

As per the above-mentioned price action and technical indicators analysis, Falcon Energy Materials PLC is looking technically well-placed on the chart, and a ‘Speculative Buy’ recommendation has been given on the stock. The summary of recommendations is as follows:

Intensity Therapeutics, Inc. (NASDAQ: INTS)

Noted below are the key price indicators for the stock:

Price Action Analysis (On the Daily Chart)

On the daily chart, INTS is holding firmly above a horizontal support trendline, indicating sustained price stability and reinforcing near-term upside potential. The stock is approaching a key resistance zone around USD 0.380, which could be tested over the next 2–6 weeks if the current bullish structure remains intact. A decisive breakout above USD 0.430 would likely serve as a strong bullish catalyst, attracting increased buying interest and potentially paving the way for a more sustained upward trend.

Technical Analysis (On the Daily Chart)

On the daily chart, the 14-period RSI stands at 68.94, indicating strong bullish momentum while still leaving room for further upside. Weekly trading volumes remain steady, reflecting a consistent base of buying interest that supports the potential for continued gains. Price action also remains above the 21-period Simple Moving Average (SMA), which acts as dynamic support and reinforces the prevailing uptrend, further strengthening the overall technical outlook.

General Recommendation:

As per the above-mentioned price action and technical indicators analysis, Intensity Therapeutics, Inc. is looking technically well-placed on the chart, and a ‘Speculative Buy’ recommendation has been given on the stock. The summary of recommendations is as follows:

Investment decisions should be made depending on an individual's appetite for upside potential, risks, and any previous holdings. This recommendation is purely based on technical analysis, and fundamental analysis has not been considered in this report.

Upcoming Major Global Economic Events

Market events occur daily depending on the data's frequency and generally include updates on CPI, PPI, Core Retail Sales, Unemployment Data, etc. The upcoming week's major global economic events that could impact the S&P/TSX Venture Composite Index and listed stocks' prices are noted below.

Related Risks: This report may be looked at from a high-risk perspective and recommendation is provided for a short duration. Recommendations provided in this report are solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Kalkine reports are prepared based on the stock prices captured from either REFINITIV or Trading View. Typically, REFINITIV or Trading View may reflect stock prices with a delay which could be a lag of 25-30 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’

Note 1: Individuals can consider exiting from the stock if the Target Price or Stop loss mentioned as per the technical analysis has been achieved and subject to the factors discussed above.

Note 2: How to Read the Charts?

The Green color line reflects the 21-period moving average, while the red color line indicates the 50-period moving average. SMA helps to identify existing price trend. If the prices are trading above the 21-period and 50-period moving average, then it shows prices are currently trading in a bullish trend.

The Black color line in the chart's lower segment reflects the Relative Strength Index (14-Period), which indicates price momentum and signals momentum in trend. A reading of 70 or above suggests overbought status, while a reading of 30 or below suggests an oversold status.

The Blue color bars in the chart's lower segment show the volume of the stock. The volume is the number of shares that changed hands during a given day. Stocks with high volumes are more liquid than stocks with lesser volume. Liquidity in stocks helps in easier and faster execution of the order.

The Orange color lines are the trend lines drawn by connecting two or more price points and used for trend identification purposes. The trend line also acts as a line of support and resistance.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: In general, it is a level to protect further losses in case of unfavorable movement in the stock prices.

Risk Reward Ratio: The risk reward ratio is the difference between an entry point to a stop loss and profit level and the report is based on ~80% Stop Loss of the Target 1 from the entry point.

A trailing stop-loss is a modification of stop-loss in case of favorable movement in the price to protect the gains. Individual can Trail the Stop-Loss as per the levels if the stock price achieves more than 50% of the Target 1. Individual should consider exiting from the position as per the Trailing Stop-Loss level if the price starts moving downwards after achieving more than 50% of the Target 1.

The reference date for all price data, currency, technical indicators, support, and resistance levels is October 09, 2025. The reference data in this report has been partly sourced from REFINITIV.

Abbreviations

CMP: Current Market Price

SMA: Simple Moving Average

CAD: Canadian Dollar

RSI: Relative Strength Index

USD: United States dollar

Note: Trading decisions require a thorough analysis by individuals. Technical reports in general chart out metrics that may be assessed by individuals before any stock evaluation. The above are illustrative analytical factors used for evaluating the stocks; other parameters can be looked at along with additional risks per se. Past performance is neither an indicator nor a guarantee of future performance.


Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Past performance is not a reliable indicator of future performance.